| Literature DB >> 29772742 |
Héctor Argüello1,2, Beatriz Guerra3,4, Irene Rodríguez5, Pedro Rubio6, Ana Carvajal7.
Abstract
Antimicrobial resistance (AMR) and Salmonella spp., are primary concerns in public health. The present study characterizes the AMR determinants of 62 multi-drug resistant (MDR) Salmonella enterica spp., isolates from swine, which were obtained between 2004⁻2006, a major source of human salmonellosis. The AMR determinants were investigated by PCR, checking the presence of class 1 and class 2 integrons and 29 resistance genes. Genes sul1, blaTEM1-like, aadA2, tet(A), and dfrA12 were more prevalent (p < 0.05) within the determinants that were checked for each of these antimicrobials. Co-existence of different genes conferring resistance to the same antimicrobial was common. No differences in AMR determinants prevalence were observed between Salmonella Typhimurium and other serovars from the study. Class 1 integrons were detected in 48 of 62 isolates, again with no differences being linked to any serovar. Nine different variable regions were observed, 1000 bp/aadA2-1200 bp/blaPSE-1 (13 isolates) and blaOXA-like/aadA1 (eight isolates) were the most common. Four isolates, including S. Typhimurium (2), Salmonella Bredeney (1), and Salmonella Kapemba (1) harboured a class 2 integron 2300 bp estX-sat2-aadA1. Results from the study highlight the importance of class 1 integrons and certain genes in MDR swine Salmonella isolates. The information is of relevance for monitoring in the forthcoming scope of reduction of antibiotic usage in swine production.Entities:
Keywords: antibiotic; food-borne pathogen; public health; resistance gene; swine
Year: 2018 PMID: 29772742 PMCID: PMC5977196 DOI: 10.3390/genes9050256
Source DB: PubMed Journal: Genes (Basel) ISSN: 2073-4425 Impact factor: 4.096
Antimicrobial resistance patterns detected in a collection of 62 multi-drug resistant Salmonella isolates that were recovered from swine.
| No. of Isolates | Antimicrobial Resistance Pattern | Serotype(s) |
|---|---|---|
| 1 | AMP-SMX-TMP | |
| 1 | SPE-SMX-TET | |
| 1 | AMP-SMX-SPE-STR | |
| 4 | AMP-SPE-STR-TET | |
| 2 | SMX-SPE-STR-TET | |
| 1 | AMP-SMX-SPE-STR-TMP | |
| 1 | AMP-SPE-STR-TET-TMP | |
| 1 | CHL-SMX-SPE-STR-TET | |
| 2 | FOT-SMX-SPE-STR-TET | |
| 1 | SMX-SPE-STR-TET-TMP | |
| 1 | AMP-CHL-FFN-SPE-STR-TET | |
| 1 | AMP-CHL-NEO-SPE-STR-TET | |
| 2 | AMP-CHL-SMX-SPE-STR-TET | |
| 1 | AMP-SMX-SPE-STR-TET-TMP | |
| 1 | CHL-CIP-FFN-GEN-NAL-SMX | |
| 6 | AMP-CHL-FFN-SMX-SPE-STR-TET | |
| 3 | CHL-FFN-SMX-SPE-STR-TET-TMP | |
| 1 | AMP-CIP-FOT-NAL-SMX-SPE-STR | |
| 1 | AMP-FOT-KAN-GEN-SPE-STR-TET | |
| 1 | AMP-FOT-NEO-SMX-SPE-STR-TET | |
| 1 | AMP-FOT-NEO-SMX-SPE-STR-TMP | |
| 1 | AMP-FOT-SMX-SPE-STR-TET-TMP | |
| 1 | APR-CHL-FFN-GEN-SMX-SPE-STR-TET | |
| 1 | AMP-APR-CEP-GEN-SMX-SPE-STR-TET | |
| 1 | AMP-CEP-CHL-SMX-SPE-STR-TET-TMP | |
| 2 | AMP-CHL-CIP-NAL-SMX-SPE-STR-TET | |
| 1 | AMP-CHL-FFN-NAL-SMX-SPE-STR-TET | |
| 1 | AMP-CHL-FFN-SMX-SPE-STR-TET-TMP | |
| 1 | AMP-CHL-NAL-SMX-SPE-STR-TET-TMP | |
| 1 | AMP-CEP-CIP-SMX-SPE-STR-TET-TMP | |
| 1 | AMP-GEN-KAN-SMX-SPE-STR-TET-TMP | |
| 1 | CHL-CIP-FFN-GEN-NAL-SMX-SPE-STR | |
| 1 | CHL-CIP-NAL-SMX-SPE-STR-TET-TMP | |
| 1 | AMP-APR-CEP-GEN-SMX-SPE-STR-TET-TMP | |
| 1 | AMP-CEP-COL-GEN-SMX-SPE-STR-TET-TMP | |
| 1 | AMP-CHL-FOT-GEN-KAN-SMX-SPE-STR-TET | |
| 1 | AMP-CHL-CIP-FFN-FOT-NAL-SMX-SPE-STR-TET | |
| 1 | AMP-CHL-GEN-KAN-SMX-SPE-STR-TET-TMP | |
| 1 | CHL-CIP-FFN-NAL-SMX-SPE-STR-TET-TMP | |
| 1 | AMP-CHL-CIP-FFN-NEO-SMX-SPE-STR-TET-TMP | |
| 2 | AMP-APR-CEP-CHL-GEN-SMX-SPE-STR-TET-TMP | |
| 1 | AMP-APR-CHL-FFN-GEN-SMX-SPE-STR-TET-TMP | |
| 1 | AMP-CEP-CHL-CIP-NAL-NEO-SMX-SPE-STR-TMP | |
| 1 | AMP-CHL-CIP-FFN-FOT-NAL-NEO-SPE-STR-TET | |
| 1 | AMP-CHL-CEP-GEN-SPE-SMX-SPE-STR-TET-TMP | |
| 1 | AMP-APR-CEP-CIP-CHL-FFN-GEN-NAL-SMX-SPE-STR-TET-TMP | |
| 1 | AMP-APR-CEP-CHL-CIP-FFN-GEN-NAL-NEO-SMX-SPE-STR-TET-TMP |
AMC: amoxicillin; AMP: ampicillin; APR: apramycin; CEP: cephalothin; XNL: ceftiofur; CIP: ciprofloxacin; CHL: chloramphenicol; COL: colistin; FFN: florphenicol; GEN: gentamicin; NAL: nalidixic acid; NEO: neomycin; SPE: spectinomycin; STR: streptomycin; SMX: sulphamethoxazole; TMP: trimethoprim/sulfamethoxazole; TET: tetracycline.
Frequencies of antimicrobial resistance determinants examined in a collection of 62 multi-drug resistant Salmonella isolates recovered from swine.
| Antimicrobial Compound 1 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Sulphonamides | 34 isolates | 5 isolates | 5 isolates | 3 isolates | 2 isolates | 1 isolate | 1 isolate | 1 isolate | 1 isolate |
| 26 (76.5%) | 5 (100%) | 4 (80%) | 3 (100%) | 1 (50%) | 1 (100%) | 1 (100%) | 1 (100%) | 1 (100%) | |
| 9 (26.5%) | 2 (40%) | 1 (20%) | 1 (33%) | 1 (50%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | |
| 12 (35.2%) | 2 (40%) | 0 (0%) | 1 (33%) | 1 (50%) | 0 (0%) | 0 (0%) | 0 (0%) | 1 (100%) | |
| Ampicillin | 33 isolates | 4 isolates | 2 isolates | 3 isolates | 1 isolate | 1 isolate | 1 isolate | 1 isolate | 1 isolate |
| bla | 21 (63.6%) | 3 (75%) | 1 (50%) | 2 (66%) | 1 (100%) | 1 (100%) | 1 (100%) | 0 (0%) | 1 (100%) |
| bla | 4 (12.1%) | 0 (0%) | 1 (50%) | 1 (33%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
| bla | 11 (33.3%) | 1 (25%) | 0 (0%) | 1 (33%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
| Tetracycline | 38 isolates | 4 isolates | 4 isolates | 3 isolates | 1 isolate | 1 isolate | 1 isolate | 1 isolate | 0 isolates |
| 19 (50%) | 4 (100%) | 4 (100%) | 3 (100%) | 1 (100%) | 1 (100%) | 1 (100%) | 1 (100%) | - | |
| 13 (34.2%) | 0 (0%) | 1 (25%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | - | |
| 11 (28.9%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 1 (100%) | 0 (0%) | - | |
| Amphenicols | 27 isolates | 3 isolates | 1 isolate | 2 isolates | 1 isolate | 1 isolate | 1 isolate | 0 isolates | 1 isolate |
| 8 (29.6%) | 1 (33.3%) | 0 (0%) | 0 (0%) | 0 (0%) | 1 (100%) | 1 (100%) | - | 0 (0%) | |
| 12 (44.4%) | 2 (66.6%) | 0 (0%) | 1 (50%) | 0 (0%) | 0 (0%) | 0 (0%) | - | 1 (100%) | |
| 12 (44.4%) | 1 (33.3%) | 1 (100%) | 1 (50%) | 1 (100%) | 0 (0%) | 0 (0%) | - | 0 (0%) | |
| Spectinomycin/Streptomycin | 41 isolates | 4 isolates | 5 isolates | 3 isolates | 2 isolates | 1 isolate | 1 isolate | 1 isolate | 1 isolate |
| 32 (78%) | 3 (75%) | 4 (80%) | 3 (100%) | 2 (100%) | 1 (100%) | 1 (100%) | 1 (100%) | 1 (100%) | |
| 24 (58.5%) | 4 (100%) | 4 (80%) | 0 (0%) | 0 (0%) | 1 (100%) | 0 (0%) | 0 (0%) | 0 (0%) | |
| Trimethoprim | 14 isolates | 5 isolates | 1 isolate | 3 isolates | 2 isolates | 1 isolate | 0 isolates | 1 isolate | 1 isolate |
| 2 (16.7%) | 1 (20%) | 1 (100%) | 1 (33%) | 2 (100%) | 1 (100%) | - | 0 (0%) | 1 (100%) | |
| 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | - | 1 (100%) | 0 (0%) | ||
| 10 (71.4%) | 0 (0%) | 1 (33%) | 0 (0%) | 0 (0%) | - | 0 (0%) | 0 (0%) | ||
| 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | - | 0 (0%) | 0 (0%) | ||
| 3 (21.4%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | - | 0 (0%) | 0 (0%) | ||
| Kanamycin | 2 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 |
| 2 (100%) | - | 1 (100%) | - | - | 1 (100%) | - | - | ||
| 0 (0%) | - | 0 (0%) | - | - | 0 (0%) | - | - | ||
| Gentamicin | 10 | 3 | 1 | 1 | 0 | 0 | 1 | 0 | 0 |
| 10 (100%) | 3 (100%) | 1 (100%) | 0 (0%) | - | - | 1 (100%) | - | - | |
| 0 (0%) | 0 (0%) | 0 (0%) | 1 (100%) | - | - | 0 (0%) | - | - | |
| 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | - | - | 0 (0%) | - | - |
Quinolones are not included in the table as all the isolates resistant to NAL were negative to the quinolone resistance genes tested (qnrS, qnrB, qnrC, qnrD).
Figure 1Percentage (%) of positive isolates to each resistance gene for SMX, AMP, TET, CHL, SPE/STR and TMP in a collection of 62 multi-drug resistant Salmonella isolates that were recovered from swine. Black bars include the 62 isolates, while grey bars report the same information only for the 43 S. Typhimurium isolates. Significant differences (p < 0.05) in prevalence of a certain genetic determinant within the collection or for S. Typhimurium isolates is denoted with an asterisk above the back or grey bars, respectively (*).
Class 1 and class 2 integrons detected in a collection of 62 multi-drug resistant Salmonella isolates recovered from swine.
| Amplicon Size/Resistance Gene | Gene Cassettes Detected in the Isolates Carrying the Class 1 and Class 2 Integrons a | No of Isolates | Serotypes |
|---|---|---|---|
| 1000-bp/ | 6 | ||
| 1000-bp/ | 3 | ||
| 1000-bp/ | 13 | ||
| 1600-bp/ | 3 | ||
| 1600-bp/dfrA17-aadA5 | 1 | ||
| 1600-bp/aac(3)-aadA7 | 1 | ||
| 1900 bp/ dfrA12-orfF-aadA2 | 3 | ||
| 2000-bp/bla | 6 | ||
| 200-bp | 4 | ||
| Defectivea,b | 8 | ||
| 2300 bp/ | 4 |
Defective integron, undetectable by 5’ CS/3’ CS primers. PCR products were observed using the following primer sets: int1-R + dfrA12-R; Presence of empty variable regions class1 integrons as well.